PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Pioneering use of oral cholera vaccine during outbreak

2013-10-18
(Press-News.org) Contact information: Sandra Murillo
Sandra.Murillo@newyork.msf.org
212-763-5765
Public Library of Science
Pioneering use of oral cholera vaccine during outbreak In a report publishing October 17th, 2013 in PLOS Neglected Tropical Diseases, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its scientific research arm, Epicentre, present results of one of the first-ever, large-scale use of an oral cholera vaccine during a cholera outbreak – a major breakthrough in the understanding and future control of deadly cholera epidemics.

Using results from a mass vaccination campaign of more than 300,000 people conducted in Guinea last year, MSF and Epicentre show the feasibility of implementing a mass vaccination campaign with oral cholera at the onset of an outbreak, similar to the way reactive vaccination campaigns are conducted when diseases such as measles or meningitis are reported in an area.

Last year, MSF teams in Guinea noticed cases of cholera months ahead of the rainy season. These early cholera cases and other factors, including the lack of a cholera epidemic in Guinea for several years, and the ongoing cholera epidemic in neighboring Sierra Leone, were strong indications to MSF and the Ministry of Health that a major cholera epidemic was imminent.

Starting in April of last year the Guinean Ministry of Health and MSF administered 316,250 doses of vaccine during two vaccination rounds in the coastal districts of Boffa and Forecariah, Guinea over six weeks. All individuals older than 12 months were eligible for vaccination in both rounds. The vaccination campaign was well accepted by the local community and MSF achieved high coverage rates. The two doses vaccine coverage was 75.8% in Boffa and 75.9% in Forecariah, respectively. Almost all people surveyed after the campaign, 98.9 percent, reported that they would be vaccinated again in a future cholera campaign.

Oral cholera vaccine was added to the WHO recommendation for cholera treatment in 2010, but so far has not been commonly used as a public health tool for control of the disease. Concerns about its feasibility, timeliness and acceptability by population, as well as fear of diverting resources from other medical programs have discouraged the use of an oral cholera vaccine.

"With this study, we show that with proper planning and outreach in the communities, it is indeed possible to vaccinate hundreds of thousands of people in a remote area, with a highly mobile population, in a relatively short period of time, against cholera," said Dr. Francisco Luquero, the paper's principal investigator. "However, more evidence is still needed about the feasibility of reactive campaigns in densely populated urban areas. Oral cholera vaccines should not be viewed as a long-term solution for global cholera control. They should be integrated as an additional tool in the global response to cholera outbreaks."

INFORMATION:

END



ELSE PRESS RELEASES FROM THIS DATE:

5-year-old children are as likely to suffer from bilharzia as their mothers

2013-10-18
5-year-old children are as likely to suffer from bilharzia as their mothers Children of women harboring the bilharzia (schistosomiasis) worm during pregnancy are more likely to suffer the infection by the age of five years, a new study publishing October 17th, ...

To sleep, perchance to clean

2013-10-18
In findings that give fresh meaning to the old adage that a good night's sleep clears the mind, a new study shows that a recently discovered system that flushes waste from the brain is primarily active during sleep. This revelation could transform scientists' understanding of the biological purpose of sleep and point to new ways to treat neurological disorders. "This study shows that the brain has different functional states when asleep and when awake," said Maiken Nedergaard, M.D., D.M.Sc., co-director of the University of Rochester Medical Center (URMC) Center for ...

The sly maneuvers of the fungus fatal to frogs

2013-10-18
This news release is available in Spanish. Like subsurface ninjas, the cells of a particular fungus are slipping into the skins of amphibians worldwide, killing them, and now a new study hints at why this particular fungus has been so successful. In 1998, a new species of chytrid fungus called Batrachochytrium dendrobatidis was identified. In recent decades, it has contributed to rendering dozens of frog species extinct, researchers think. They know the fungus inserts itself into the skin of frogs, drying out a layer they require to be hydrated, but just how the ...

Complete skull from early Homo evokes a single, evolving lineage

2013-10-18
This news release is available in French and Arabic. What if the earliest members of our Homo genus—those classified as Homo habilis, Homo rudolfensis, Homo erectus and so forth—actually belonged to the same species and simply looked different from one another? That's precisely the implication of a new report, which describes the analysis of a complete, approximately 1.8-million-year-old skull that was unearthed in Dmanisi, Georgia. Unlike other Homo fossils, this skull, known as Skull 5, combines a small braincase with a long face and large teeth. It was ...

Researchers rewrite an entire genome -- and add a healthy twist

2013-10-18
Scientists from Yale and Harvard have recoded the entire genome of an organism and improved a bacterium's ability to resist viruses, a dramatic demonstration of the potential of rewriting an organism's genetic code. "This is the first time the genetic code has been fundamentally changed," said Farren Isaacs, assistant professor of molecular, cellular, and developmental biology at Yale and co-senior author of the research published Oct. 18 in the journal Science. "Creating an organism with a new genetic code has allowed us to expand the scope of biological function in ...

Vitamin D does not contribute to kidney stones, study asserts

2013-10-18
Increased vitamin D levels may prevent a wide range of diseases, according to recent studies. However, some previous studies led to a concern that vitamin D supplementation could increase an individual's risk of developing kidney stones. However, a study of 2,012 participants – published in the American Journal of Public Health –found no statistically relevant association between 25-hydroxyvitamin D (25 (OH)D) serum level in the range of 20 to 100 ng/mL and the incidence of kidney stones. This study – led by Cedric F. Garland, DrPH, adjunct professor in the Division ...

Natural selection enables purple loosestrife to invade northern Ontario

2013-10-18
TORONTO, ON - University of Toronto research has found that purple loosestrife – an invasive species that competes with native plants for light and nutrients and can degrade habitats for wildlife – has evolved extremely rapidly, flowering about three weeks earlier as it has spread to northern Ontario. This has allowed populations of the species to thrive in the colder climate with a more than 30-fold increase in seed production. "The ability of invasive species to rapidly adapt to local climate has not generally been considered to be an important factor affecting spread," ...

Field Museum scientists estimate 16,000 tree species in the Amazon

2013-10-18
Researchers, taxonomists, and students from The Field Museum and 88 other institutions around the world have provided new answers to two simple but long-standing questions about Amazonian diversity: How many trees are there in the Amazon, and how many tree species occur there? The study will be published October 17, 2013 in Science. The vast extent and difficult terrain of the Amazon Basin (including parts of Brazil, Peru, Columbia) and the Guiana Shield (Guyana, Suriname, and French Guiana), which span an area roughly the size of the 48 contiguous North American states, ...

Frog-killing fungus paralyzes amphibian immune response

2013-10-18
A fungus that is killing frogs and other amphibians around the world releases a toxic factor that disables the amphibian immune response, Vanderbilt University investigators report Oct. 18 in the journal Science. The findings represent "a step forward in understanding a long-standing puzzle – why the amphibian immune system seems to be so inept at clearing the fungus," said Louise Rollins-Smith, Ph.D., associate professor of Pathology, Microbiology and Immunology. Although the identity of the toxic fungal factor (or factors) remains a mystery, its ability to inhibit a ...

Costly cigarettes and smoke-free homes

2013-10-18
Researchers at the University of California, San Diego School of Medicine say high-priced cigarettes and smoke-free homes effectively reduce smoking behaviors among low-income individuals – a demographic in which tobacco use has remained comparatively high. Writing in the October 17, 2013 issue of the American Journal of Public Health, principal investigator John P. Pierce, PhD, professor and director of population sciences at UC San Diego School of Medicine, and colleagues found that expensive cigarettes – $4.50 or more per pack – were associated with lower consumption ...

LAST 30 PRESS RELEASES:

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

[Press-News.org] Pioneering use of oral cholera vaccine during outbreak